Finasteride topical - Acrux

Drug Profile

Finasteride topical - Acrux

Alternative Names: Finasteride MDTS

Latest Information Update: 02 Feb 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Acrux
  • Class Androstenes; Antiacnes; Antiandrogens; Antineoplastics; Azasteroids; Small molecules
  • Mechanism of Action Cholestenone 5-alpha reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alopecia

Most Recent Events

  • 02 Feb 2011 Discontinued - Preclinical for Alopecia in Australia (Topical)
  • 02 Feb 2011 Discontinued - Preclinical for Alopecia in USA (Topical)
  • 23 May 2005 Acrux and Napa Biosciences have entered into an exclusive worldwide licensing agreement to develop and commercialise certain prescription and over-the-counter dermatology products for various skin disorders, including alopecia
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top